Impact of Ki67 on pathological complete response rate after neoadjuvant CRT in cT3N0M0 rectal cancer

被引:0
|
作者
Adua, D. [1 ]
Giaccherini, L. [2 ]
Guido, A. [2 ]
Cuicchi, D. [3 ]
Di Fabio, F. [1 ]
Llimpe, F. L. Rojas [1 ]
Macchia, G. [4 ]
Cammelli, S. [2 ]
Fuccio, L. [3 ]
Ardizzoni, A. [1 ]
Morganti, A. G. [2 ]
机构
[1] St Orsola Marcello Malpighi Hosp, Dept Med Oncol, Bologna, Italy
[2] Univ Bologna, St Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, DIMES,Radiat Oncol Unit, Bologna, Italy
[3] Univ Bologna, Dept Med & Surg Sci, DIMEC, Bologna, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Ric & Cura Giovanni Paolo II, Radiotherapy Unit, Campobasso, Italy
关键词
D O I
10.1016/S0167-8140(17)31707-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP-1272
引用
收藏
页码:S683 / S684
页数:2
相关论文
共 50 条
  • [1] Role of Neoadjuvant Treatment in cT3N0M0 Rectal Cancer
    Pasetto, Lara Maria
    Friso, Maria Luisa
    Pucciarelli, Salvatore
    Basso, Umberto
    Rugge, Massimo
    Sinigaglia, Giulietta
    Rossi, Elena
    Compostella, Alessia
    Toppan, Paola
    Agostini, Marco
    Monfardini, Silvio
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4129 - 4135
  • [2] Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer
    Naiken, Surennaidoo P.
    Toso, Christian
    Rubbia-Brandt, Laura
    Thomopoulos, Theodoros
    Roth, Arnaud
    Mentha, Gilles
    Morel, Philippe
    Gervaz, Pascal
    BMC SURGERY, 2014, 14
  • [3] Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer
    Surennaidoo P Naiken
    Christian Toso
    Laura Rubbia-Brandt
    Theodoros Thomopoulos
    Arnaud Roth
    Gilles Mentha
    Philippe Morel
    Pascal Gervaz
    BMC Surgery, 14
  • [4] Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?
    Rubio, Gustavo A.
    Hurst, Roger D.
    Umanskiy, Konstantin
    Shogan, Benjamin D.
    Hyman, Neil
    Olortegui, Kinga Skowron
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (02) : 479 - 482
  • [5] Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?
    Gustavo A. Rubio
    Roger D. Hurst
    Konstantin Umanskiy
    Benjamin D. Shogan
    Neil Hyman
    Kinga Skowron Olortegui
    Journal of Gastrointestinal Surgery, 2022, 26 : 479 - 482
  • [6] The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location
    Kohada, Yuki
    Hayashi, Tetsutaro
    Takemoto, Kenshiro
    Miyamoto, Shunsuke
    Babasaki, Takashi
    Kobatake, Kohei
    Kitano, Hiroyuki
    Ikeda, Kenichiro
    Goto, Keisuke
    Hieda, Keisuke
    Honda, Yukiko
    Sentani, Kazuhiro
    Oue, Naohide
    Awai, Kazuo
    Hinata, Nobuyuki
    UROLOGY JOURNAL, 2024, 21 (02) : 98 - 106
  • [7] COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT THERAPY IN RECTAL CANCER: DOES YPT0 ALSO MEAN YPN0?
    Shankar, B.
    Raghunath, R.
    Jesudason, M.
    DISEASES OF THE COLON & RECTUM, 2017, 60 (06) : E104 - E105
  • [8] The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
    Zhang, Lu-Ning
    Xiao, Weiwei
    OuYang, Pu-Yun
    You, Kaiyun
    Zeng, Zhi-Fan
    Ding, Pei-Rong
    Pan, Zhi-Zhong
    Xu, Rui-Hua
    Gao, Yuan-Hong
    TUMOR BIOLOGY, 2015, 36 (10) : 8213 - 8219
  • [9] Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
    Yoshioka, Tatsuya
    Hosoda, Mitsuchika
    Yamamoto, Mitsugu
    Taguchi, Kazunori
    Hatanaka, Kanako C.
    Takakuwa, Emi
    Hatanaka, Yutaka
    Matsuno, Yoshihiro
    Yamashita, Hiroko
    BREAST CANCER, 2015, 22 (02) : 185 - 191
  • [10] Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
    Tatsuya Yoshioka
    Mitsuchika Hosoda
    Mitsugu Yamamoto
    Kazunori Taguchi
    Kanako C. Hatanaka
    Emi Takakuwa
    Yutaka Hatanaka
    Yoshihiro Matsuno
    Hiroko Yamashita
    Breast Cancer, 2015, 22 : 185 - 191